Evidence
Neurology. 2024 Feb 27;102(4):e209237. doi: 10.1212/WNL.0000000000209237. Epub 2024 Jan 24.
NO ABSTRACT
PMID:38266209 | DOI:10.1212/WNL.0000000000209237
Estimated reading time: 1 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Reader Response: Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Reader Response: What Is the Ideal Brain Criterion of Death? Nonclinical Considerations: The UDDA Revision Series
- Reader Response: Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline: Report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM
- Intrinsic Capacity as a Risk Factor for Dementia: A New Hope
- Intrinsic Capacity as a Risk Factor for Dementia: A New Hope
- Intrinsic Capacity as a Risk Factor for Dementia: A New Hope
- What Can Blood Biomarkers Tell Us About Patients With Lewy Body Dementia?
- Author Response: What Is the Ideal Brain Criterion of Death? Nonclinical Considerations: The UDDA Revision Series
- Right Brain: Death Protocols
- Stroke Thrombolysis: Can You Feel the Need for Speed?
- What Is the Role of Lactate in Brain Metabolism, Plasticity, and Neurodegeneration?
- Pontine Demyelination With Synkinesis of the Bilateral Sixth and Seventh Cranial Nerves
- Absence of a Superior Colliculus Causing Gaze Deviation in a 6-Month-Old Boy: Case Report
- Teaching Video NeuroImage: Who Says Only Cardiologists Need Good Ears: Listening to Neurologic Footfall
- Predicting Driving Cessation in Alzheimer Disease: Performance Beats Biomarkers
- Editors' Note: What Is the Ideal Brain Criterion of Death? Nonclinical Considerations: The UDDA Revision Series
- Dynamic Tracking of Brain Health via Interrogation of Sleep Networks With Cardiopulmonary Coupling Sleep Spectrograms
- Population Dementia Incidence and Direct Oral Anticoagulant Use in a Representative Population With Atrial Fibrillation
- Reproductive History and Lifetime Brain Health: The Rise of Cognitive-Neuro-Obstetrics
- Right Brain: The Unraveling
- Embolic Stroke of Undetermined Source: New Data and New Controversies on Cardiac Monitoring and Anticoagulation
- Opinion & Special Article: Community Approach Toward Inclusion of Sex and Gender Diversity in Graduate Neurology Education
- Prediction of Large Vessel Occlusion Stroke Using Clinical Registries for Research
- Prognostic Value of CSF IL-10 at Early Assessment of Induction Chemotherapy in Primary CNS Lymphomas: A LOC Network Study
- Association of Antithrombotic Drug Use With Incident Intracerebral Hemorrhage Location
- Forensic Neurology: Practice Considerations and Training Opportunities
- Proportion of Community-Dwelling Individuals Older Than 70 Years Eligible for Lecanemab Initiation: The Gothenburg H70 Birth Cohort Study
- Proportion of Community-Dwelling Individuals Older Than 70 Years Eligible for Lecanemab Initiation: The Gothenburg H70 Birth Cohort Study
- Boston Criteria v2.0 for Cerebral Amyloid Angiopathy Without Hemorrhage: An MRI-Neuropathologic Validation Study
- Bridging the Gap: Local Field Potentials Offer a Peek Into the Brain of a Person With Parkinson Disease
- Gene-Gene Interaction Between Factor-XI and ABO Genes in Cerebral Venous Thrombosis: The BEAST Study
- Outcomes of Patients With Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease at 3 and 5 Years After Diagnosis
- Dementia in Rare Genetic Neurodevelopmental Disorders: A Systematic Literature Review
- Pearls & Oy-sters: AARS2 Leukodystrophy-Tremor and Tribulations
- Trajectories of Occupational Cognitive Demands and Risk of Mild Cognitive Impairment and Dementia in Later Life: The HUNT4 70+ Study
- Prevalence of Suicidality in Adolescents With Newly Diagnosed Focal Epilepsy at Diagnosis and Over the Following 36 Months
- Assessment of Small Vessel Function Using 7T MRI in Patients With Sporadic Cerebral Small Vessel Disease: The ZOOM@SVDs Study
- Patent Foramen Ovale Closure in Older Patients With Stroke: Patient Selection for Trial Feasibility
- Assessment of Skin Biopsy as a Diagnostic Biomarker in CSF1R-Related Disorder
- Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM
- Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM
- Burden of Neurologic Health Care and Incident Neurologic Diagnoses in the Year After COVID-19 or Influenza Hospitalization
- Glutamate Signaling in Patients With Parkinson Disease With REM Sleep Behavior Disorder
- Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies
- Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism
- Predicting Driving Cessation Among Cognitively Normal Older Drivers: The Role of Alzheimer Disease Biomarkers and Clinical Assessments
- Pathologic Features of Anti-Ku Myositis
- Regional Burden of Enlarged Perivascular Spaces and Cognition and Neuropsychiatric Symptoms in Drug-Naive Patients With Parkinson Disease
- Associations Between Blood-Based Biomarkers and Cognitive and Functional Trajectories Among Participants of the MEMENTO Cohort
- Associations Between Age at Menopause, Vascular Risk, and 3-Year Cognitive Change in the Canadian Longitudinal Study on Aging
- Association of NOTCH3 Variant Risk Category With 2-Year Clinical and Radiologic Small Vessel Disease Progression in Patients With CADASIL
- Prescribed Drug Use and Aneurysmal Subarachnoid Hemorrhage Incidence: A Drug-Wide Association Study
- Cross-Sectional and Longitudinal Association of Clinical and Neurocognitive Factors With Apathy in Patients With Parkinson Disease
- Implications of Large Language Models for Quality and Efficiency of Neurologic Care: Emerging Issues in Neurology
- Differential Vulnerability of Hippocampal Subfields to Amyloid and Tau Deposition in the Lewy Body Diseases
- Secondary stroke prevention in people with atrial fibrillation: treatments and trials
- Associations Between Self and Study Partner Report of Cognitive Decline With Regional Tau in a Multicohort Study
- Predictors of Seizure Recurrence in Women With Idiopathic Generalized Epilepsy Who Switch From Valproate to Another Medication
- Association of Time to Thrombolysis With Early Reperfusion After Alteplase and Tenecteplase in Patients With Large Vessel Occlusion
- Differences in Cortical Morphology in People With and Without Migraine: A Registry for Migraine (REFORM) MRI Study
- Effects of Achieving Rapid, Intensive, and Sustained Blood Pressure Reduction in Intracerebral Hemorrhage Expansion and Functional Outcome
- Glycoproteome-Wide Discovery of Cortical Glycoproteins That May Provide Cognitive Resilience in Older Adults
- Perivascular Spaces, Diffusivity Along Perivascular Spaces, and Free Water in Cerebral Small Vessel Disease
- Lifetime History of Low Birth Weight Delivery and Cognitive Function in Middle-Aged Parous Women
- Ultra-Early and Short-Term Tranexamic Acid Treatment in Patients With Good- and Poor-Grade Aneurysmal Subarachnoid Hemorrhage
Evidence Blueprint
Reader Response: Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Reader Response: Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Author Response: Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study
- Editors' Note: Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study
- Reader Response: What Is the Ideal Brain Criterion of Death? Nonclinical Considerations: The UDDA Revision Series
- Bringing Evidence to the Nursing Home: Do Statins Have a Role for Prevention in Patients With and Without Dementia?
- Reader Response: Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline: Report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM
- Intrinsic Capacity as a Risk Factor for Dementia: A New Hope
- Intrinsic Capacity as a Risk Factor for Dementia: A New Hope
- Intrinsic Capacity as a Risk Factor for Dementia: A New Hope
- ICA Bonsai
- What Can Blood Biomarkers Tell Us About Patients With Lewy Body Dementia?
- Skipping, Steroids, and Genes: The First 7 Therapies for Duchenne Muscular Dystrophy
- Skipping, Steroids, and Genes: The First 7 Therapies for Duchenne Muscular Dystrophy
- Author Response: What Is the Ideal Brain Criterion of Death? Nonclinical Considerations: The UDDA Revision Series
- Right Brain: Death Protocols
- Stroke Thrombolysis: Can You Feel the Need for Speed?
- What Is the Role of Lactate in Brain Metabolism, Plasticity, and Neurodegeneration?
- Pontine Demyelination With Synkinesis of the Bilateral Sixth and Seventh Cranial Nerves
- Absence of a Superior Colliculus Causing Gaze Deviation in a 6-Month-Old Boy: Case Report
- Teaching Video NeuroImage: Who Says Only Cardiologists Need Good Ears: Listening to Neurologic Footfall
- Predicting Driving Cessation in Alzheimer Disease: Performance Beats Biomarkers
- Editors' Note: What Is the Ideal Brain Criterion of Death? Nonclinical Considerations: The UDDA Revision Series
- Dynamic Tracking of Brain Health via Interrogation of Sleep Networks With Cardiopulmonary Coupling Sleep Spectrograms
- Teaching NeuroImage: Perivascular radial enhancement in neurosarcoidosis
- Population Dementia Incidence and Direct Oral Anticoagulant Use in a Representative Population With Atrial Fibrillation
- Teaching Video NeuroImage: Dural Angioleiomyoma: Insights From Dynamic Imaging
- How Far Are We in Translating the Multiple Sclerosis Prodromes in Clinical Practice?
- Cognition, Emotion, and Cerebrocerebellar Circuit Disruption in a Patient With Hemangioblastoma
- Reproductive History and Lifetime Brain Health: The Rise of Cognitive-Neuro-Obstetrics
- From Clinical Trials to Memory Clinics, tau-PET Visual Reads Can Help Diagnosis and Patient Stratification
- Sprinting to the Finish: Optical Coherence Tomography, Retinal Atrophy, and Neurodegeneration in Progressive Multiple Sclerosis
- Right Brain: The Unraveling
- Mendelian Randomization Applied to Neurology
- Embolic Stroke of Undetermined Source: New Data and New Controversies on Cardiac Monitoring and Anticoagulation
- Emerging Subspecialties in Neurology: Women's Neurology
- Patient With Rigidity and Fasciculations
- Neuropathologic Burden and Dementia in Nonagenarians and Centenarians
- Opinion & Special Article: Community Approach Toward Inclusion of Sex and Gender Diversity in Graduate Neurology Education
- Prediction of Large Vessel Occlusion Stroke Using Clinical Registries for Research
- Prognostic Value of CSF IL-10 at Early Assessment of Induction Chemotherapy in Primary CNS Lymphomas: A LOC Network Study
- Statin Use and All-Cause Mortality in Nursing Home Residents With and Without Dementia: A Retrospective Cohort Study Using Claims Data
- Pearls & Oy-sters: CACNA1A-Related Paroxysmal Tonic Upgaze With Ataxia Responsive to Acetazolamide
- Association of Plasma YKL-40 With MRI, CSF, and Cognitive Markers of Brain Health and Dementia
- Long-Term Longitudinal Course of Cognitive and Motor Symptoms in Patients With Cerebral Small Vessel Disease
- Racial and Ethnic Differences in the Population-Attributable Fractions of Alzheimer Disease and Related Dementias
- Association of Antithrombotic Drug Use With Incident Intracerebral Hemorrhage Location
- Bridging the Gap: Immunotherapy in Progressive Multifocal Leukoencephalopathy: A New Hope?
- Forensic Neurology: Practice Considerations and Training Opportunities
- Montreal Cognitive Assessment and the Clock Drawing Test to Identify MCI and Predict Dementia in Isolated REM Sleep Behavior Disorder
- Sleep Characteristics and Risk of Stroke and Dementia: An Observational and Mendelian Randomization Study
- Progressive Multifocal Leukoencephalopathy: Pathogenesis, Diagnostic Tools, and Potential Biomarkers of Response to Therapy
- Child Neurology: Progressive Cerebellar Atrophy and Retinal Dystrophy - Clues to an Ultra-Rare ACO2-Related Neurometabolic Diagnosis
- Proportion of Community-Dwelling Individuals Older Than 70 Years Eligible for Lecanemab Initiation: The Gothenburg H70 Birth Cohort Study
- Proportion of Community-Dwelling Individuals Older Than 70 Years Eligible for Lecanemab Initiation: The Gothenburg H70 Birth Cohort Study
- Child Neurology: Mucopolysaccharidosis IIID: Evidence From Ultrastructural and Genomic Study
- Boston Criteria v2.0 for Cerebral Amyloid Angiopathy Without Hemorrhage: An MRI-Neuropathologic Validation Study
- Bridging the Gap: Local Field Potentials Offer a Peek Into the Brain of a Person With Parkinson Disease
- Gene-Gene Interaction Between Factor-XI and ABO Genes in Cerebral Venous Thrombosis: The BEAST Study
- Lecanemab Questions
- Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease: A Cohort Study
- SARS-CoV-2 Infection and Risk of Postacute Psychiatric and Neurologic Diagnoses: A Nationwide Danish Cohort Study
- Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology
- 99mTc-HMPAO SPECT Perfusion Signatures Associated With Clinical Progression in Patients With Isolated REM Sleep Behavior Disorder
- Outcomes of Patients With Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease at 3 and 5 Years After Diagnosis
- Cost-Effectiveness of Lecanemab for Individuals With Early-Stage Alzheimer Disease
Indementia